T-Net49 分钟
Eupraxia's DiffuSphere Technology Demonstrates Targeted Drug Release while Minimizing ...
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, unveiled new pharmacokinetic ("PK") data from its Phase 2a Eosinophilic Esophagitis ("EoE") program.